|Current Year Total Award (In Millions)
*amount of No Cost Extension ending 9/29/2021
The Illinois Department of Human Services Division of Substance Use Prevention and recovery (IDHS/SUPR) has been awarded multiple grants to address the opioid crisis, from the Substance Abuse and Mental Health Services Administration (SAMHSA), a branch of the U.S. Department of Health and Human Services (HHS). This report focuses on the State Opioid Response (SOR) grant funding. Past Overdose Response Funding has been removed from this report and can be obtained by request from Kathleen.Monahan@Illinois.gov .
The grants include initiatives that align with the State Overdose Action Plan (SOAP). The SOAP forms the strategic framework for addressing the overdose epidemic in Illinois, setting a statewide goal of reducing the number of overdose deaths, and formulating a set of evidence-based strategies to achieve this goal. The SOAP focuses on efforts in five categories:
- Social Equity
- Treatment and Recovery
- Harm Reduction
- Justice-Involved Populations and Public Safety
Each priority includes a set of metrics that will be used to document our progress. The programs supported through these grants are designed to address the range of serious overdose-related problems and issues that are being experienced among residents across Illinois. These programs primarily aim to address the overdose crisis by expanding the availability of medication assisted treatment (MAR), improving the quality of the MAR provided, enhancing access to treatment, reducing overdose related deaths, increasing public awareness of overdose-related problems and expanding access to the resources that are available to address these problems. More resources about opioids can be found at https://www.dhs.state.il.us/page.aspx?item=93882
IDHS/SUPR will post new opportunities for competitive bids through the Notice of Funding Opportunity (NOFO) process included in Illinois' implementation of the Government Accountability and Transparency Act (GATA) requirements. Further information about these projects will be available as new NOFOs are released on SUPR's NOFO page at https://www.dhs.state.il.us/page.aspx?item=114615
*Population-based activities, such as public awareness campaigns, the Helpline, and Naloxone distribution, are not included in this number but are summarized below.
September 2021 Update and Summary
As of March 2020, SUPR has begun using the term Medication Assisted Recovery (MAR) to replace the term Medication Assisted Treatment (MAT). Medication Assisted Recovery (MAR) includes the use of evidence- based FDA approved medications (e.g., methadone, buprenorphine, naltrexone, disulfiram, acamprosate) for individuals with a substance use disorder (SUD) who are in recovery. The term MAR recognizes that individuals who take medications to manage their SUD who identify in recovery are in recovery since often these medications are prescribed long term and are used outside of treatment. Older documents might still use the term MAT.
IDHS/SUPR received notice of an award from SAMHSA for the next round of SOR funding of $36.7 million. The project period is 9/30/2020 through 9/29/2022, for a total of $73.5 million over two years. SUPR continues to fund the work of programs in this report and has initiated some new projects as well. These include: MAR Integration for Justice-Involved Populations; Leadership Centers; and Access Narcan. Descriptions of these projects are included in this report. As always, new Notice of Funding Opportunities will be posted here: https://www.dhs.state.il.us/page.aspx?item=114615
Illinois Opioid Crisis Helpline
SOR funds support a statewide 24-hour, 7-day/week, 365 day/year helpline for persons with OUD-related issues. https://helplineil.org The Helpline was launched on December 5, 2017 and has received 54,643 calls as of September 30, 2021. The Helpline's website was launched I n March 2018 and has received 267,989 visits by 201,840 unique individuals as of September 30, 2021. During 2020, texting was added to the Helpline telephone technology, and a chat function was added to the Helpline website, opening more opportunities for people to seek and receive help. New marketing campaigns were implemented statewide, including television ads in the Chicago market to focus on the West Side heroin epidemic. The Recovery Housing registry is now managed by the Helpline. Additionally, Helpline partnered with the Illinois Department of Public Health (IDPH) to design a harm reduction campaign, leading people to resources for syringe services, fentanyl test strips, and other harm reduction supports. Results of those campaigns will be shared in an upcoming report.
Improved Medical Provider Electronic Health Record (EHR)
The Illinois Prescription Monitoring Program (PMP) receives Controlled Substance prescription data from retail pharmacies which enables prescribers and dispensers to view the historical data for current and prospective patients. Prescribers are required to review the PMP when considering opioids for individual patients, but this manual process is burdensome for medical practitioners in a busy practice. IDHS/SUPR is supporting a portion of the PMP's PMPnow campaign, an effort to support improved opioid prescriber reporting in commonly used EHR systems among Illinois medical provider systems. These "automated connections" make it more convenient for prescribers to check the PMP through their EHR, rather than logging into an external system. Senate Bill 722 (SB722), which took effect on January 1, 2018, mandates that all prescribers possessing an Illinois Control Substance license must register with the PMP. The PMP attributes the new law, along with the increase in automated connections, to a massive influx of PMP registrations. As of August 30, 2021, there were 1,159 PMP/EHR connectivity implementations (PMPnow), and 75,999 registered PMP users. As of September 30, 2021, 8,307,250 searches were conducted through PMP now requests. More information on PMPnow can be found here: https://www.ilpmp.org/PMPnow.html
OUD Public Awareness Activities
Public Awareness approaches are underway to deliver messaging and education to various audiences regarding the impacts of the opioid crisis in Illinois and the availability of programs and activities that have been developed in response. Primary campaigns that are ending include Guard and Discard and Ending Opioid Misuse in Illinois. In June 2019, IDSH/SUPR added an important component to the overall statewide public awareness campaign by launching the A Dose of Truth (ADOT) campaign. The ADOT campaign started with a focus on creating a baseline of knowledge in the general population about what are opioids, specifically those found in medicine cabinets, and has evolved overtime to focus on the current drivers of overdose and overdose death in Illinois. This includes the need to address the ever-increasing crisis of opioid overdose and racial disparities. The initial Dose of Truth campaign focus includes social media Facebook posts reaching an estimated 18,049,187 individuals, engaged (likes, comments and shares and more) 75,849 individuals, and had 3,008,400 video views (video played for at least 3 seconds and excludes replaying the video during a single instance). In June 2019, IDHS/SUPR added another public awareness campaign, Naloxone Now. The Naloxone Now campaign addresses issues of stigma and acceptance of this life-saving medication within the general population, equating it to other life-saving medications and devices. The Naloxone Now campaign has ended June 2020 components were integrated into the current ADOT campaign. As of October 31, 2020, for messaging that included interior rail and bus cards displayed on Chicago's trains and buses, final numbers are an estimated 543.2 million impressions and 12.75 million impressions through PACE interior bus cards and bus shelters. Final numbers for displays through gas stations and convenience stores statewide include an estimated 131.4 million views and 37,675,400 million views for bar restrooms signage.
An increasing need was identified to demystify Medication Assisted Recovery (MAR) and encourage both prescribers and patients to discuss its effectiveness in treating OUDs, implications in treating an SUD in the context of recovery, and ultimately its effectiveness in decreasing overdose deaths. This led to the development and implementation of the Rethink Recovery campaign. Rethink Recovery is a statewide public awareness campaign that seeks to increase an openness and interest in MAR among those at high risk of overdose. This campaign facilitates the first steps towards recovery by providing education and resources directly to those in-need and their support systems
New reach numbers are being reported to reflect the change in the ADOT campaign. As of September 30, 2021, the ADOT campaign has 9,189,437 Social Media Impressions (Social Media Impressions are the number of times that paid or unpaid content was displayed/seen by someone), 2,521,863 Social Media Engagements (Social Media Engagements are the number of actions a person took on campaign content, including post likes/reactions, photo views, link clicks, post saves, video/gif completions, shares/retweets, comments/replies, and page likes/follows), and 34,098 Website Sessions (Website Sessions are a single visit to a campaign website. As of September 30, 2021, for the Rethink Recovery campaign, there have been 17,686 Website Sessions and 87 pdf downloads.
Student Athlete OUD Primary Prevention Services
IDHS/SUPR supports a regional program that focuses on the risk of increased access to opioid pain medications for student-athletes. The Student- Athlete Opioid Use Prevention Project conducts educational and awareness activities that target high school coaches, athletic directors, parents, and student-athletes regarding the misuse and risk of misuse of prescribed opiate pain medications by youth athletes. These activities include training on the Rx Playbook and dissemination of awareness promoting key messages, partnering with key organizations who focus on High School athletes, collaborating with existing prevention resources to promote key messages, promoting the Rx Playbook to targeted High Schools, and establishing social media connections with targeted schools and athletes attending those schools. As of September 30th: The Rx Playbook has been shared at 37 county, statewide, and national events, and conferences, reaching 1,575 school staff, parents, and/or community members. Comprehensive opioid education and awareness materials have been distributed to over 163 prevention providers and grantees (DHS-SUPS, SAMHSA-DFC, CSUPS). Social media activities include a total of 118,883 reaches on Twitter and 229,402 reaches on Facebook and 59,951 engagements on our newly launched Instagram page. The project website received in total over 38,107-page views with 4,280 visits to the Rx Playbook pages. In addition, the project has launched 4 self-paced online training courses. The Athletic Trainer's Role in Opioid Education (https://academy.ilhpp.org/courses/athletico-presentation), Adolescent's and Opioids (https://academy.ilhpp.org/courses/jason-video-course )Opioid 101 (https://academy.ilhpp.org/courses/opioid-1-course-test ), and Be Your Own Best Advocate (https://academy.ilhpp.org/courses/be-your-own-best-advocate-1) .
Expansion of OUD Primary Prevention Services
IDHS/SUPR awarded ORF grant funds to a cadre of primary prevention providers, who are already networked with Illinois schools, to support implementation of the evidence based My Generation Rx program. My Generation Rx, the adolescent version of Generation Rx, educates teens about the potential dangers of misusing prescription medications. It includes resources designed to educate teens about the importance of using medications safely, as well as teaching teens the key skills needed to turn down invitations to misuse substances and positive alternatives to cope with the demands of life. During the 2018/2019 school year, more than 16,900 youth received this evidenced-based opioid focused education across Illinois across 68 prevention provider organization sites. The number of youths served during the 2019/2020 school year decreased due to the pandemic's impact on youth reach. As of October 31, 2020, 10,397 youth had been served through 44 prevention provider organization sites for the 2019/2020 school year.
Treatment and Recovery Initiatives
Access to Medication Assisted Recovery (A-MAR) Networks
Over 90% of Illinois citizens live in a county with at least one form of MAR available. However, there are 39 Illinois counties that are considered "MAR deserts", with no MAR providers located within their geographic boundaries. One of IDHS/SUPR's approaches to increase access to MAR is via the AMAR Project. The AMAR Project utilizes a "Hub and Spoke" model, the goal of which is to have a substantial population center working with the surrounding "MAR desert" areas. Illinois has implemented five AMAR Networks, two that were implemented in November 2018 (one in central Illinois and the other in the southern area of the state) and an additional three that began client admissions in June 2019. All five networks were identified via the NOFO process. Through September 30, 2021, 1,178 clients have been admitted to MAR through these service networks. More information about this project, including a map of the AMAR locations, is posted at https://www.dhs.state.il.us/page.aspx?item=115412
Residential Stabilization Centers for Patients with Opioid Use Disorder
These resources are targeted to the current gap in the service continuum for persons with OUD who lack housing and other supports to effectively engage in MAR during the early stage of their recovery process. Residential/inpatient care is expensive and unnecessarily restrictive for many persons with MAR, but many individuals still need safe, stable, temporary housing and supports like clothing, meals, and access to mental health services and primary health care.
Through the NOFO process three providers were identified, and one provider began services in September 2019. As of September 30, 2021, 575 clients have been admitted to the Residential Stabilization Centers.
Recovery Homes are alcohol and drug free homes whose rules, peer-led groups, staff activities and/or other structured operations are meant to help with maintaining sobriety. ORF grants have allowed IDHS/SUPR to expand Recovery Home services for persons with OUD who have unstable living arrangements and are active in some form of MAR. Through the state's NOFO process, three recovery home organizations were identified to provide expanded services for persons with OUD in June 2017, four were identified in August 2018, and four more awards were made effective on July 1, 2019.As of September 30, 2021, 809 clients have been admitted to a recovery home.
More information about recovery homes can be found here: https://helplineil.org/app/account/opa_result/incident_id/NTgyNzU=#description
Correctional Facility-Based MAR Services
Injectable naltrexone is the form of medication assistance for OUD that is most often preferred by correctional facility administrators because it has no risk of diversion. Federal ORF grant funds support six organizations providing injectable Naltrexone services for persons with OUD in county jails and at the Sheridan Correctional Center, one of Illinois' prisons.
These services consist of screening, assessment, initial injections, and post-release treatment referrals before discharge. Services have been implemented at 18 county jails, with services in the planning stage at several additional jails. Through September 30, 2021 317 persons have been served. About 95% of these offenders were admitted by the community-based treatment providers to which they were referred.
Learning Collaborative to Support MAR Implementation for the Justice-Involved Population in Illinois Counties
This program offers expert technical assistance (TA) for county teams starting or expanding medication assisted recovery (MAR) programs in their jail with continued recovery support in the community post-release. It expands upon the injectable naltrexone project by moving counties towards offering all three forms of federally approved medications for opioid use disorder (MOUD.) Currently eight jails (Kane, Kendall, Grundy, Will, Lake, DuPage, Iroquois, LaSalle) are participating in the program with their county team that includes custody officers, SUD and BH healthcare providers, probation, health departments, and others.
Five organizations were chosen to support the development of a comprehensive statewide network to assess and move persons with SUD through treatment and recovery, helping to bring together the numerous programs created in IL in response to the overdose crisis. Centers plan, develop and manage relationships and connections between traditional SUD services and the medical system, integrating prevention, treatment, and recovery. Centers expand the use of recovery support services within each region and through their provider networks, including interventions for co-occurring medical/mental illness. This program is still in start-up and continues to evolve.
Co-Located Hospital Warm Hand-off Services
Patients who arrive at a hospital emergency department (ED) after an overdose reversal are at high risk of subsequent overdose. Additionally, patients in other hospital departments June have undiagnosed OUD. Hospitals don't typically screen for substance use disorders routinely, so patients with OUD are not often discharged with a referral to address their opioid use. Hospital Warm Hand-off Services involve robust, evidence-based screening and referral to treatment. Peer recovery support specialists "warm up" the referral to MAR services by going beyond providing a written referral or scheduling an appointment. It involves establishing a collaborative relationship with the patient, providing practical, personalized support for entering and adhering to treatment, and, in coordination with treatment providers, delivering ongoing recovery support services based upon patient needs. Five organizations have been contracted to provide ORF grant-supported co- located screening and warm hand-off services for persons with OUD in Illinois hospitals. the Co- located Hospital Warm Hand-off Services have been initiated at 15 hospitals and multiple Cook County Health (CCH) locations, with 8,141 patients served through September 30, 2021. Over 70% of these patients were admitted by the community- based treatment providers to which they were referred following discharge.
Hospital Screening and Warm Handoff Services
This is an expansion of the Co-Located Hospital Warm Hand-off Services, whereby hospitals provide grant-supported services directly rather than through sub agreements with external organizations. These services build upon the co-located hospital warm hand- off ORF grant awards in that services will be available throughout the hospital, and at more extended period time. Service delivery is consistent with the evidence-based Screening, Brief Intervention, and Referral to Treatment (SBIRT) model that has been the focus of multiple SAMHSA-funded cooperative agreements and discretionary grants. The number of patients screened positive for OUD and referred to treatment post discharge is 3,442 through September 30, 2021
Rush University Hospital Multi-Disciplinary Programs
IDHS/SUPR funds support multiple programs within Rush University Hospital, which is located on the west side of Chicago. As of July 2021, Rush provided Screening, Brief Intervention, and Referral to Treatment (SBIRT) services to 25,813 patients, of whom 6,149 screened positive for any SUD, with 2,600 of these patients screening positive for OUD. Buprenorphine services were initiated for 559 patients, 345 patients were referred to other MAR services, and 661 non-OUD patients were referred to external SUD providers.
Community-based Outreach/Linkage/Referral Services
Specialized and specific community-based outreach, referral, and linkage services are offered for persons with OUD in high-need areas. As a means of identifying individuals who are currently using heroin or other illicit opioids, peer outreach workers canvass multiple locations that are frequented by high-risk individuals, such as parks, street corners, public transportation stations, mini-marts, and liquor stores. Through the end of September 2021: 8,002 persons were provided outreach services; 5,146 of these persons screened positive for opioid and other illegal substance use and expressed an interest in treatment; 2,937 of these completed a meeting with a linkage manager; and 2,359 presented for the treatment intake.
Service Enhancement for Pregnant and Postpartum Women with OUD
Enhanced services are made available to pregnant and postpartum women with OUD by staff who are certified in the following evidenced-based practices: Community Reinforcement and Family Training (CRAFT), Motivational Interviewing, Seeking Safety, Real Life Parenting, Individual Placement and Support (IPS) Employment. The staffing pattern for the supported enhancement will include Doula Certified Recovery Coaches. A Doula Certified Recovery Coach is a person in active recovery who obtains dual certification as both a birth and a postpartum doula to assist the recovering mother through prenatal and postpartum phases, and with recovery from her addiction. Services have been initiated by the five providers which were selected through the NOFO process. As of September 30, 2021, 1,177 women have been admitted to these enhanced services More information about this project is posted at https://www.dhs.state.il.us/page.aspx?item=117624.
Opioid Use Disorder (OUD) MAR in Federally Qualified Health Centers (FQHC)
The intent of this initiative is to increase the number of persons who are receiving MAR at FQHCs in Illinois. FQHCs can bill Medicaid for the medications and supportive services that make up MAR, so this grant will support services for patients that are not Medicaid-eligible, and services that are not Medicaid-billable. Such services include case management and recovery support services. Through the NOFO process five providers were identified and services began in November 2019. As of September 30, 2021, 52 clients have been admitted to these services.
In order to retain patients in MAR and offer additional supports, Illinois Recovery Community Organizations (RCOs) and SUPR-licensed providers have been awarded funds and technical assistance to develop digital recovery support toolkits including secure messaging, web resources, and recovery support mobile applications (apps) for persons with OUD who are active in some form of MAR. Through the NOFO process five providers were identified and began services in December 2019. As of September 30, 2021, 384 clients have been admitted to these services.
Technical Assistance for MAR Providers
Rush Fellowship has developed a comprehensive weekend program for training and supporting medical staff to prescribe and treat individuals with the medication buprenorphine. Patients with OUD can be medically complex and sometimes medical staff are hesitant to treat these patients. The purpose of the program is to provide technical assistance to office-based buprenorphine prescribers in Illinois, especially within counties with limited or no current access to MAR. Physicians who have successfully begun prescribing buprenorphine share their challenges, successes and words of wisdom to assist their colleagues in breaking down the challenges to providing MAR. Rush recruited a cohort of 21 prescribers who participated in an immersion weekend that was held on the Rush campus on November 17-18, 2018. A second cohort of 19 prescribers was held on March 23-24, 2019, third cohort of 19 prescribers was trained on July 27-28, 2019, and a fourth cohort of 22 prescribers was trained on January 18-19, 2020. A fifth cohort began in October 2020 with 40 participants attending virtually. A sixth cohort began May 1st with 42 participants. A total of 163 prescribers have participated in these services to-date. Ongoing technical assistance, including coaching and additional training, is being provided to these cohorts. Several rural counties are represented by prescribers who have thus far enrolled, and senior fellows who have been through the training are now assisting to gain experience for mentoring in their own communities.
Expanded Naloxone Purchase/Training/Distribution Services
Naloxone is a medication that reverses an overdose by blocking opioids, including prescription opioids, heroin, and fentanyl. Federal funds are used for naloxone purchase, training, and distribution to traditional first responders like law enforcement officers and fire departments as well as non-traditional first responders like people who use drugs, friends and family members of people who use drugs, and other bystanders or community members who June witness an opioid overdose. As, 2021, there have been 91,511 first responders trained, over 138,200 naloxone kits have been distributed, and 7,456 reported overdose reversals.
Beginning in July of 2021, SUPR has instituted a program "Access Narcan" that allows organizations interested in distributing Narcan to apply online to become a Drug Overdose Prevention Program (DOPP) and order Narcan, paid for by the State. More information can be found here: https://www.dhs.state.il.us/page.aspx?item=58142
Community Reinforcement Approach (CRA)
CRA is an evidence-based treatment for substance use disorders and has been shown to be effective for both stimulant and opioid use disorders, especially in combination with contingency management. CRA training is for clinicians and clinical supervisors. SUPR funds this training for any of our treatment providers where appropriate. During the period January 31, 2021 through September 29, 2021, 176 individuals have completed CRA training workshops. Of the 176trainees, 52 are currently working on certification, and 11 recently attended November, January, March, May, or July trainings. Another training begins in September 2021 and 9 persons are registered for this training. For more information about the CRA model, training, and certification, visit https://www.chestnut.org/ebtx
Data and Outcomes
IDHS/SUPR has taken multiple steps to comply with SAMHSA expectations regarding administration of the CSAT GPRA tool to each person who participates in the treatment and recovery services supported by this grant. The Illinois SOR grant has a two-year cumulative target of 4,500 unduplicated clients for the 10 service programs that contribute to this target.
Illinois SOR-I funded services have been provided to more than double the grant target of 4,500 clients since project start. 9,525 clients have been recruited over the entire grant period, including 3,980 during the current reporting period. Of the 7706 participants due for a 6-month follow up since project start, 6527 follow-ups were completed.
For the SOR-I project as a whole (6527 records with both a baseline and 6-month follow up):
- There were statistically significant reductions from the month before intake to the month before follow up in 15+ days using heroin/opioids (71% to 18%), as well as decreases in 15+ days use of other substance including cocaine/crack (16% to 4%).
- Participants also experienced significant decreases in mental health symptoms, including reductions in 15+ days of anxiety (30% to 21%) and depression (27% to 17%), and experiencing physical health problems (57% to 36% reporting poor/fair health).
- Conversely, there were significant increases in 15+ times utilizing substance use treatment including MAT (22% to 47%).
- Improvement in these domains was also seen in the majority of SOR service types. There was some variability in outcomes across service types, reflecting the differences in baseline levels of severity among participants in the different service types.
For the SOR-II project, Illinois SOR-II has recruited and provided 1,030 clients with SOR-funded services during the current time frame. Of the 361 participants due for a 6-month follow up to date, 249 follow-ups have been completed (69%). Among the 249 clients with both a baseline and 6-month follow up:
- There were statistically significant reductions from the month before intake to the month before follow up in 15+ days using heroin/opioids (37% to 11%), as well as decreases in 15+ days use of other substances including cocaine/crack/methamphetamines (19% to 6%).
- Participants also experienced significant decreases in mental health symptoms, including reductions in 15+ days of anxiety (34% to 21%), and in physical health problems (56% to 33% reporting poor/fair health).
- Conversely, there were significant increases in 15+ times utilizing substance use treatment including MAT (26% to 36%).
- Improvements in these domains were generally seen within each SOR-II service type. There was some variability in outcomes across service types, reflecting the differences in baseline levels of severity among participants in the different service types.
Summary of Funding Sources
Provided below is a brief overview of the funding sources, collectively referenced as the Overdose Response Funding and described above. Each of these grants were awarded by the Substance Abuse and Mental Health Services Administration (SAMHSA). Grants that have ended have been removed from this report.
Grant to Prevent Prescription Drug/Opioid Overdose Related Deaths (IPDO)
Illinois received IPDO (SP022140) in 2016. It is a five-year discretionary grant funded at $1 million/year. The goals of the project are to 1) expand the existing infrastructure responsible for assessing, planning, and implementing strategies to prevent overdose-related deaths; 2) reduce the numbers of overdose- related deaths in six high-need counties; 3) increase the availability of Naloxone to first responders; and measure the short and long-term outcomes of the program. The total award is $5 million, and the grant period is September 2016 - August 2021.
State Opioid Response (SOR) Grant
SOR-I: Illinois initially received $29.0 million in grant funding for two years (TI081699) through the SAMHSA SOR Grant. SOR Year 1 funds were increased through a supplemental award of $15.1 million. The grant period is from October 2018 - September 2020, and funds total $73.1 million. These funds support the expansion of treatment and recovery support interventions across the state, MAR services for individuals with OUD who are incarcerated in county jails, and resources for hospitals to help link patients experiencing opioid overdoses to treatment programs in their communities. Housing for persons in recovery from opioid use disorder and supportive services for patients at FQHCs are also supported as part of the grant. The award also strengthens and enhances the Illinois Prescription Monitoring Program (PMP), to continue the state's efforts to prevent the misuse of prescription opioids. In addition, this grant continues support of the availability of naloxone.
SOR-II: In September 2020, Illinois received $36.7million in grant funding from SAMHSA for the next year of SOR funding. (SOR-II) A second year is contingent on fund availability. The grant period is from Sept 30, 2020 through Sept 29, 2021. Projects in development under the new grant include: expansion of medication assisted recovery and support for persons involved in the criminal justice system; enhanced support for federally qualified health centers to enhance their treatment and support of persons with opioid use disorder; creation of regional centers to coordinate the provider systems and networks within their regions. Additionally, this grant expands the pool of those who can be served to now include persons with stimulant use disorder. All programs funded through this award will either expand existing effective programs or will be developed as pilots and put out for bid through the Notice of Funding Opportunity (NOFO) process included in Illinois' implementation of the Government Accountability and Transparency Act (GATA) requirements. See here for more info on NOFOs: https://www.dhs.state.il.us/page.aspx?item=114615